In the face of the upcoming 2025, the "Action Plan for the High-Quality Development of the Pharmaceutical Industry (2023-2025)" has also ushered in a critical year. Looking back over the past three years, China's pharmaceutical industry has made remarkable breakthroughs under the framework of the action plan. Today, pharmaceutical companies are standing at a meeting point full of development potential and opportunities. How to grasp policy opportunities and rely on innovative strategies to promote the pharmaceutical industry to move towards high-end, intelligent and green is the focus of widespread attention and hot topics in the industry.
In 2025, as a strong boost to the internationalization process of China's pharmaceutical industry, PMEC China will join hands with CPHI China to jointly promote the exchange and trade of global pharmaceutical manufacturing equipment technology with a record display scale.
PMEC China 2025 is committed to deeply cultivating the integration of the whole chain of resources in the pharmaceutical industry, accurately focusing on hot market categories and potential growth areas, and has planned seven themed exhibition areas. These exhibition areas are closely connected with the needs of domestic and foreign markets, providing broad and unlimited opportunities for enterprises to adjust their production layout and accelerate the process of transformation and upgrading.